Renal Denervation Insights

Published: 12 February 2021

  • Views:

    Views Icon 28502
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension

Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.



Medical Education Program

Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension

This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management. 


Click here to watch:

IME series

CME education

This educational content is supported by Medtronic.

More from this programme

Part 2

Science of Radiofrequency Renal Denervation

Experts explain the mechanism of action behind radiofrequency renal denervation, including evidence demonstrating long-term safety and efficacy.

Faculty Biographies

Isabella Sudano

Isabella Sudano

Specialist in Internal Medicine with special training in hypertension and dyslipidemia and a genuine passion for preventive medicine; lecturer at the University of Zürich and PhD in cardiovascular research. Head of the hypertension and dyslipidemia facilities of the heart center and of the smoking cessation clinic of the university Hospital Zurich. Her research focuses on vascular research (endothelial function in micro- as well as macrocirculation, vascular compliance and atherosclerotic changes of the carotid artery). Actual president of the Swiss Society of Hypertension, Member of the Board of the swiss working group on lipid and atherosclerosis, FESC and Nucleus Member of the Hypertension Council of the European Society of Cardiology.

Dr Isabella Sudano is on the Editorial Board of European Cardiology Review.

View full profile